Paris-based firm Ardian has build on its strong portfolio performance of the past year in raising $9 billion for its latest flagship control buyout fund, Ardian Buyout Fund VII.
Already, the $110 billion firm has committed to eleven investments. The most recent transactions include Inovie (medical laboratory testing, France), ANGUS (specialty additives focused on life sciences and personal care, U.S., AD Education (creative arts education platform, France), Jakala (digital marketing, Italy) and GBA (food and environmental testing, Germany).
Thibault Basquin, head of Americas Investments at Ardian Buyout (provided)
Officials said it has gathered . . .
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.